The Medicine Maker

June 29, 2019

The cannabis business is booming and pharma is looking to get in on the action with new business models and potential new drugs derived from the cannabis plant.

Spotlight

Enable Injections, Inc.

Enable Injections is pioneering a new class of drug delivery technology, the wearable high-volume injector, that industry experts are calling “truly revolutionary.” Winner of Buzz of BIO Investor Forum and other accolades, the Enable Injections technology is designed to allow easy, comfortable self-administration of the more than 900 high volume, viscous biologics in development--promising new drugs to treat a host of conditions from cancers and autoimmune diseases to genetic and rare diseases that, because of the large doses required, cannot be delivered with today’s legacy injection technology. Founded in 2010 by medical device industry veterans, the company has R&D and manufacturing facilities in Franklin, Ohio.

OTHER WHITEPAPERS
news image

Pharma R And D Review

whitePaper | February 11, 2021

Welcome to Pharmaprojects’ 2021 review of trends in pharmaceutical R&D. For almost 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article I’ll examine the state of play at the start of 2021.

Read More
news image

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Read More
news image

National Council for Prescription Drug Programs

whitePaper | May 12, 2022

This document is Copyright © 2022 by the National Council for Prescription Drug Programs (NCPDP). It may be freely redistributed in its entirety provided this copyright notice is not removed.

Read More
news image

Why Deck 7

whitePaper | January 1, 2020

With over 2,800 campaigns each year delivered through a team of 300+ digital, data, and technology specialists, Deck 7 is a first resource for B2B demand generation services for marketers worldwide. Clients leverage Deck 7’s multichannel content marketing services and Media 7’s network of 30+ online publications for content syndication to engage over 95 million buyers across 16 industries and 120+ countries.

Read More
news image

Defragmenting Data for the Future of Pharma R&D

whitePaper | November 7, 2019

This in-depth paper will show you how to become data agile – tackling both technological issues and solutions, and the cultural and strategic framework needed around this to ensure success.

Read More
news image

Application Notes & Whitepapers 2019

whitePaper | December 19, 2019

Welcome to European Pharmaceutical Review’s Application Notes & Whitepapers Supplement 2019. This year’s topics range from analytical techniques for bioprocess investigation, host cell protein analysis and Raman imaging to advice on outsourcing services for product characterisation.

Read More

Spotlight

Enable Injections, Inc.

Enable Injections is pioneering a new class of drug delivery technology, the wearable high-volume injector, that industry experts are calling “truly revolutionary.” Winner of Buzz of BIO Investor Forum and other accolades, the Enable Injections technology is designed to allow easy, comfortable self-administration of the more than 900 high volume, viscous biologics in development--promising new drugs to treat a host of conditions from cancers and autoimmune diseases to genetic and rare diseases that, because of the large doses required, cannot be delivered with today’s legacy injection technology. Founded in 2010 by medical device industry veterans, the company has R&D and manufacturing facilities in Franklin, Ohio.

Events